Skip to main content
MGRX
NASDAQ Industrial Applications And Services

Mangoceuticals Receives Nasdaq Delisting Notice for Sub-$1.00 Bid Price

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$0.382
Mkt Cap
$6.222M
52W Low
$0.34
52W High
$6.15
52W Position info
12% above low
Off High info
94% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

MGRX is trading near its 52-week low of $0.34 (12% above the low) on light trading volume (0.1× avg).

Summary

MANGOCEUTICALS, INC. received a Nasdaq deficiency notice for failing to meet the minimum $1.00 bid price requirement, initiating a 180-day period to regain compliance and avoid potential delisting.


Key Events · Corporate Governance and Compliance · MGRX

  • Nasdaq Deficiency Notice Received

    On February 4, 2026, Mangoceuticals received a notification from Nasdaq for non-compliance with Listing Rule 5550(a)(2), as its common stock bid price closed below $1.00 for 30 consecutive business days.

  • 180-Day Compliance Period

    The company has 180 calendar days, until August 3, 2026, to regain compliance. This requires the stock's bid price to close at $1.00 or more for a minimum of 10 consecutive business days.

  • No Immediate Impact on Listing

    Nasdaq's notice currently has no effect on the listing or trading of the company's common stock. The company intends to monitor its stock price and consider options to resolve the deficiency.


Analysis · MGRX · Industrial Applications And Services

MANGOCEUTICALS, INC. has received a deficiency notification from Nasdaq for failing to maintain a minimum bid price of $1.00 per share for 30 consecutive business days. This is a critical event for a micro-cap company as continued listing on a major exchange is vital for liquidity and investor confidence. The company has 180 calendar days, until August 3, 2026, to regain compliance by having its stock close at or above $1.00 for at least 10 consecutive business days. Failure to do so could lead to delisting, which would severely impact the stock's tradability and investor perception. The company's current stock price of $0.382 is significantly below the required threshold, indicating a challenging path to compliance.

How filings like this one have moved

In the 30 days to Sep 30, 2026, 41.9% of the 322 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.38%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MGRX was trading at $0.38 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $6.2M. The 52-week trading range was $0.34 to $6.15. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MGRX - Latest Insights

MGRX
Aug 21, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.4021
Real-time Price: $0.435 info
Change: +$0.0329 (+8%) info
Market Cap: $9.233M info
MGRX
Aug 13, 2026, 5:27 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.625
Real-time Price: $0.435 info
Change: -$0.190 (-30%) info
Market Cap: $9.233M info
MGRX
Aug 13, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $0.7485
Real-time Price: $0.435 info
Change: -$0.3135 (-42%) info
Market Cap: $9.233M info
MGRX
Aug 05, 2026, 6:13 PM EDT
Filing Type: 425
Importance Score:
7
Price at Filing: $0.5363
Real-time Price: $0.435 info
Change: -$0.1013 (-19%) info
Market Cap: $9.233M info
MGRX
Aug 04, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.441
Real-time Price: $0.435 info
Change: -$0.0060 (-1%) info
Market Cap: $9.233M info